Lan Yi

U1 Adaptors Suppress the KRAS-MYC Oncogenic Axis in Human Pancreatic Cancer Xenografts

Eric S. Ho, C. Dudgeon, Xin Yu, 2017, Molecular Cancer Therapeutics.

An analysis of the role of HnRNP C dysregulation in cancers

Nanyang Yang, Lan Yi, Guoqing Li, 2022, Biomarker research.

Selected drugs that inhibit DNA methylation can preferentially kill p53 deficient cells

A. Levine, Yvonne Sun, Lan Yi, 2014, Oncotarget.

Multiple roles of p53-related pathways in somatic cell reprogramming and stem cell differentiation.

A. Levine, Wenwei Hu, Chiwei Lu, 2012, Cancer research.

Downregulation of NSD3 (WHSC1L1) inhibits cell proliferation and migration via ERK1/2 deactivation and decreasing CAPG expression in colorectal cancer cells

Chen Li, Lanjuan Yi, Lan Yi, 2019, OncoTargets and therapy.